ARDELYX, INC. — Director's Dealing 2017

Mar 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2017-03-10

Reporting Person: Rosenbaum David P. (SVP, Drug Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-10	Common Stock	S	1000	$13.4823	Disposed	1277	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	42180	Direct
Common Stock	77592	Indirect

Footnotes

F1: Includes 364 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.

F2: Consists of 1,277 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.

F3: The shares are directly held by the Reporting Person's wife.

F4: Includes (i) 2,051 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017 and (ii) 17,985 restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F5: The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.